Buprenorphine utilization following removal of prior authorization requirements in the Kentucky Medicaid population
Removal of transmucosal buprenorphine PA requirements for Kentucky Medicaid enrollees was associated with a significant immediate increase in buprenorphine dispensing for OUD treatment. Future research should evaluate how post-PA removal trends interact with the Kentucky Medicaid's coverage of methadone for OUD beginning in Q3/2019.
Authors
- Sharon Walsh
- Michelle R. Lofwall
- Lindsey R. Hammerslag
- Dustin K. Miracle
- Patricia R. Freeman
Institutions
- University of Kentucky (US)
Publication Details
- Journal
- Drug and Alcohol Dependence
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1016/j.drugalcdep.2026.113105
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00